{
  "id": "trigeminal-neuralgia",
  "title": "Trigeminal Neuralgia",
  "version": "1.0",
  "icd10": [
    "** G50.0 (Trigeminal neuralgia)",
    "G50.1 (Atypical facial pain)",
    "G50.8 (Other disorders of trigeminal nerve)",
    "G44.847 (Trigeminal autonomic cephalalgia)"
  ],
  "scope": "** Evaluation and management of trigeminal neuralgia in adults including classical TN (with or without neurovascular compression), secondary TN, and painful trigeminal neuropathy. Covers medical management, procedural interventions, and surgical options. Applies to ED, hospital, and outpatient settings.",
  "notes": [],
  "sections": {
    "Laboratory Workup": {
      "Core Labs (Baseline Before Treatment)": [
        {
          "item": "CBC (CPT 85025)",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-",
          "rationale": "Baseline for carbamazepine (bone marrow suppression)",
          "target": "Normal"
        },
        {
          "item": "CMP (CPT 80053) (sodium, LFTs)",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-",
          "rationale": "Carbamazepine: hyponatremia, hepatotoxicity",
          "target": "Normal"
        },
        {
          "item": "HLA-B*1502 (Asian ancestry)",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-",
          "rationale": "SJS/TEN risk with carbamazepine in Asian populations",
          "target": "Negative"
        }
      ],
      "Extended Labs (Atypical Presentations)": [
        {
          "item": "ESR (CPT 85652), CRP (CPT 86140)",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "EXT",
          "ICU": "-",
          "rationale": "If vasculitis or GCA suspected (elderly, V1)",
          "target": "Normal"
        },
        {
          "item": "ANA (CPT 86235), SSA/SSB",
          "ED": "-",
          "HOSP": "-",
          "OPD": "EXT",
          "ICU": "-",
          "rationale": "Sjögren syndrome can cause trigeminal neuropathy",
          "target": "Negative"
        },
        {
          "item": "CSF analysis (CPT 62270)",
          "ED": "-",
          "HOSP": "EXT",
          "OPD": "EXT",
          "ICU": "-",
          "rationale": "If MS or CNS infection suspected",
          "target": "Normal; or MS-consistent findings"
        },
        {
          "item": "ACE level (CPT 82164)",
          "ED": "-",
          "HOSP": "-",
          "OPD": "EXT",
          "ICU": "-",
          "rationale": "Neurosarcoidosis",
          "target": "Normal"
        }
      ]
    },
    "Imaging & Studies": {
      "Neuroimaging": [
        {
          "item": "MRI brain with dedicated trigeminal protocol (CPT 70553)",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-",
          "timing": "All patients; before treatment",
          "target": "Identify neurovascular compression, tumor, MS plaques",
          "contraindications": "Pacemaker, metal"
        },
        {
          "item": "MRA (CPT 70544) (if MRI equivocal)",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "EXT",
          "ICU": "-",
          "timing": "Evaluate vascular loop",
          "target": "Define vessel relationship",
          "contraindications": "Same"
        },
        {
          "item": "CT head (CPT 70450) (if MRI unavailable)",
          "ED": "URGENT",
          "HOSP": "ROUTINE",
          "OPD": "-",
          "ICU": "-",
          "timing": "Emergent exclusion of mass",
          "target": "No mass",
          "contraindications": "None (contrast: renal)"
        }
      ],
      "Specialized Protocols": [
        {
          "item": "3D-CISS/FIESTA sequence",
          "ED": "-",
          "HOSP": "-",
          "OPD": "ROUTINE",
          "ICU": "-",
          "timing": "Pre-surgical planning",
          "target": "Define nerve-vessel relationship",
          "contraindications": "MRI contraindications"
        },
        {
          "item": "High-resolution MRI trigeminal nerve",
          "ED": "-",
          "HOSP": "-",
          "OPD": "ROUTINE",
          "ICU": "-",
          "timing": "If painful neuropathy; atypical features",
          "target": "Nerve atrophy, enhancement, mass",
          "contraindications": "Same"
        }
      ],
      "Additional Studies": [
        {
          "item": "Trigeminal reflex testing (blink reflex) (CPT 95933)",
          "ED": "-",
          "HOSP": "-",
          "OPD": "EXT",
          "ICU": "-",
          "timing": "If sensory loss; differentiate from neuropathy",
          "target": "Normal in classical TN; abnormal in secondary",
          "contraindications": "None"
        },
        {
          "item": "Dental/maxillofacial evaluation",
          "ED": "-",
          "HOSP": "-",
          "OPD": "ROUTINE",
          "ICU": "-",
          "timing": "Exclude dental pathology as pain source",
          "target": "No dental cause",
          "contraindications": "None"
        }
      ]
    },
    "Treatment": {
      "First-Line Pharmacotherapy": [
        {
          "item": "Carbamazepine (Tegretol)",
          "route": "PO",
          "indication": "-",
          "dosing": {
            "doseOptions": [
              {
                "text": "100 mg BID",
                "orderSentence": "Carbamazepine 100 mg PO BID"
              },
              {
                "text": "200 mg BID",
                "orderSentence": "Carbamazepine 200 mg PO BID"
              },
              {
                "text": "400 mg BID",
                "orderSentence": "Carbamazepine 400 mg PO BID"
              },
              {
                "text": "600 mg BID",
                "orderSentence": "Carbamazepine 600 mg PO BID"
              }
            ],
            "route": "PO",
            "instructions": "100-200 mg BID; increase by 100-200 mg q3-7 days; target 400-1200 mg/day divided BID-TID",
            "orderSentence": "Carbamazepine 100 mg PO BID"
          },
          "contraindications": "AV block, bone marrow suppression, MAOIs, Asian ancestry (check HLA-B*1502)",
          "monitoring": "CBC, LFTs, Na q2-4 weeks initially, then q3-6 months; drug levels optional",
          "ED": "ROUTINE",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "Oxcarbazepine (Trileptal)",
          "route": "-",
          "indication": "-",
          "dosing": {
            "doseOptions": [
              {
                "text": "150 mg BID",
                "orderSentence": "Oxcarbazepine 150 mg PO BID"
              },
              {
                "text": "300 mg BID",
                "orderSentence": "Oxcarbazepine 300 mg PO BID"
              },
              {
                "text": "600 mg BID",
                "orderSentence": "Oxcarbazepine 600 mg PO BID"
              },
              {
                "text": "900 mg BID",
                "orderSentence": "Oxcarbazepine 900 mg PO BID"
              },
              {
                "text": "1200 mg BID",
                "orderSentence": "Oxcarbazepine 1200 mg PO BID"
              }
            ],
            "route": "PO",
            "instructions": "150-300 mg BID; increase by 300 mg/week; target 600-1800 mg/day",
            "orderSentence": "Oxcarbazepine 150 mg PO BID"
          },
          "contraindications": "Severe hyponatremia; less drug interactions than CBZ",
          "monitoring": "Na (hyponatremia more common); CBC, LFTs less critical",
          "ED": "ROUTINE",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-"
        }
      ],
      "Second-Line Pharmacotherapy": [
        {
          "item": "Baclofen",
          "route": "PO",
          "indication": "-",
          "dosing": {
            "doseOptions": [
              {
                "text": "5 mg TID",
                "orderSentence": "Baclofen 5 mg PO TID"
              },
              {
                "text": "10 mg TID",
                "orderSentence": "Baclofen 10 mg PO TID"
              },
              {
                "text": "20 mg TID",
                "orderSentence": "Baclofen 20 mg PO TID"
              },
              {
                "text": "20 mg QID",
                "orderSentence": "Baclofen 20 mg PO QID"
              }
            ],
            "route": "PO",
            "instructions": "5 mg TID; increase by 5 mg q3 days; target 30-80 mg/day divided TID",
            "orderSentence": "Baclofen 5 mg PO TID"
          },
          "contraindications": "Renal impairment (dose reduce)",
          "monitoring": "Sedation, weakness; taper slowly to avoid withdrawal",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "Lamotrigine",
          "route": "-",
          "indication": "-",
          "dosing": {
            "doseOptions": [
              {
                "text": "25 mg daily",
                "orderSentence": "Lamotrigine 25 mg PO daily"
              },
              {
                "text": "50 mg daily",
                "orderSentence": "Lamotrigine 50 mg PO daily"
              },
              {
                "text": "100 mg daily",
                "orderSentence": "Lamotrigine 100 mg PO daily"
              },
              {
                "text": "200 mg daily",
                "orderSentence": "Lamotrigine 200 mg PO daily"
              },
              {
                "text": "400 mg daily",
                "orderSentence": "Lamotrigine 400 mg PO daily"
              }
            ],
            "route": "PO",
            "instructions": "25 mg daily × 2 weeks, then 50 mg daily × 2 weeks, then increase by 50 mg q2 weeks; target 200-400 mg/day",
            "orderSentence": "Lamotrigine 25 mg PO daily"
          },
          "contraindications": "History of rash with AEDs",
          "monitoring": "Rash (SJS risk with rapid titration); slow titration mandatory",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "Gabapentin",
          "route": "-",
          "indication": "-",
          "dosing": {
            "doseOptions": [
              {
                "text": "300 mg",
                "orderSentence": "Gabapentin 300 mg -"
              }
            ],
            "route": "-",
            "instructions": "300 mg TID; titrate to 1800-3600 mg/day; less effective than CBZ/OXC",
            "orderSentence": "Gabapentin 300 mg -"
          },
          "contraindications": "CrCl <60: reduce dose",
          "monitoring": "Sedation; renal dosing",
          "ED": "ROUTINE",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "Pregabalin",
          "route": "PO",
          "indication": "-",
          "dosing": {
            "doseOptions": [
              {
                "text": "50 mg TID",
                "orderSentence": "Pregabalin 50 mg PO TID"
              },
              {
                "text": "75 mg BID",
                "orderSentence": "Pregabalin 75 mg PO BID"
              },
              {
                "text": "100 mg TID",
                "orderSentence": "Pregabalin 100 mg PO TID"
              },
              {
                "text": "150 mg BID",
                "orderSentence": "Pregabalin 150 mg PO BID"
              },
              {
                "text": "200 mg BID",
                "orderSentence": "Pregabalin 200 mg PO BID"
              },
              {
                "text": "300 mg BID",
                "orderSentence": "Pregabalin 300 mg PO BID"
              }
            ],
            "route": "PO",
            "instructions": "75 mg BID; titrate to 150-300 mg BID",
            "orderSentence": "Pregabalin 50 mg PO TID"
          },
          "contraindications": "CrCl <60: reduce dose",
          "monitoring": "Sedation, weight gain; renal dosing",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-"
        }
      ],
      "Combination Therapy": [
        {
          "item": "Carbamazepine + Baclofen",
          "route": "-",
          "indication": "-",
          "dosing": {
            "doseOptions": [
              {
                "text": "N/A",
                "orderSentence": "Carbamazepine + Baclofen N/A -"
              }
            ],
            "route": "-",
            "instructions": "If monotherapy inadequate; use lower doses",
            "orderSentence": "Carbamazepine + Baclofen N/A -"
          },
          "contraindications": "Per individual agents",
          "monitoring": "Per individual agents",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "Carbamazepine + Lamotrigine",
          "route": "-",
          "indication": "-",
          "dosing": {
            "doseOptions": [
              {
                "text": "N/A",
                "orderSentence": "Carbamazepine + Lamotrigine N/A -"
              }
            ],
            "route": "-",
            "instructions": "Additive efficacy; CBZ induces lamotrigine metabolism (need higher LTG dose)",
            "orderSentence": "Carbamazepine + Lamotrigine N/A -"
          },
          "contraindications": "Per individual agents",
          "monitoring": "Drug interactions",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "Oxcarbazepine + Gabapentin",
          "route": "-",
          "indication": "-",
          "dosing": {
            "doseOptions": [
              {
                "text": "N/A",
                "orderSentence": "Oxcarbazepine + Gabapentin N/A -"
              }
            ],
            "route": "-",
            "instructions": "If CBZ not tolerated",
            "orderSentence": "Oxcarbazepine + Gabapentin N/A -"
          },
          "contraindications": "Per individual agents",
          "monitoring": "Hyponatremia, sedation",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-"
        }
      ],
      "Acute Exacerbation Management": [
        {
          "item": "Fosphenytoin (severe exacerbation) (CPT 96365)",
          "route": "IV",
          "indication": "-",
          "dosing": {
            "doseOptions": [
              {
                "text": "15-20 mg",
                "orderSentence": "Fosphenytoin (severe exacerbation) (CPT 96365) 15-20 mg IV"
              }
            ],
            "route": "IV",
            "instructions": "15-20 mg PE/kg IV at 100-150 mg/min; then phenytoin 100 mg TID",
            "orderSentence": "Fosphenytoin (severe exacerbation) (CPT 96365) 15-20 mg IV"
          },
          "pretreatment": "-",
          "contraindications": "Sinus bradycardia, heart block, Adams-Stokes syndrome",
          "monitoring": "ECG, BP during infusion; phenytoin levels",
          "ED": "STAT",
          "HOSP": "STAT",
          "OPD": "-",
          "ICU": "-"
        },
        {
          "item": "IV lidocaine (CPT 96365)",
          "route": "IV",
          "indication": "-",
          "dosing": {
            "doseOptions": [
              {
                "text": "1-3 mg/kg",
                "orderSentence": "IV lidocaine (CPT 96365) 1-3 mg/kg IV"
              }
            ],
            "route": "IV",
            "instructions": "1-3 mg/kg IV over 20-30 min (monitored setting); for severe refractory pain",
            "orderSentence": "IV lidocaine (CPT 96365) 1-3 mg/kg IV"
          },
          "pretreatment": "-",
          "contraindications": "Cardiac conduction abnormalities",
          "monitoring": "Continuous cardiac monitoring",
          "ED": "-",
          "HOSP": "STAT",
          "OPD": "-",
          "ICU": "-"
        },
        {
          "item": "Peripheral nerve block (V2/V3) (CPT 64400)",
          "route": "-",
          "indication": "-",
          "dosing": {
            "doseOptions": [
              {
                "text": "N/A",
                "orderSentence": "Peripheral nerve block (V2/V3) (CPT 64400) N/A -"
              }
            ],
            "route": "-",
            "instructions": "Lidocaine/bupivacaine at foramen rotundum/ovale",
            "orderSentence": "Peripheral nerve block (V2/V3) (CPT 64400) N/A -"
          },
          "pretreatment": "-",
          "contraindications": "Infection, coagulopathy",
          "monitoring": "Short-term relief",
          "ED": "ROUTINE",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-"
        }
      ],
      "Interventional Procedures (Refractory to Medical Therapy)": [
        {
          "item": "Percutaneous balloon compression",
          "route": "-",
          "indication": "-",
          "dosing": {
            "doseOptions": [
              {
                "text": "N/A",
                "orderSentence": "Percutaneous balloon compression N/A -"
              }
            ],
            "route": "-",
            "instructions": "Outpatient/short-stay; compresses gasserian ganglion",
            "orderSentence": "Percutaneous balloon compression N/A -"
          },
          "contraindications": "Coagulopathy",
          "monitoring": "Facial numbness; recurrence 20-30% at 5 years",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "-",
          "ICU": "-"
        },
        {
          "item": "Percutaneous glycerol rhizolysis",
          "route": "-",
          "indication": "-",
          "dosing": {
            "doseOptions": [
              {
                "text": "N/A",
                "orderSentence": "Percutaneous glycerol rhizolysis N/A -"
              }
            ],
            "route": "-",
            "instructions": "Injection into Meckel's cave",
            "orderSentence": "Percutaneous glycerol rhizolysis N/A -"
          },
          "contraindications": "Same",
          "monitoring": "Same; less sensory loss",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "-",
          "ICU": "-"
        },
        {
          "item": "Percutaneous radiofrequency thermocoagulation",
          "route": "-",
          "indication": "-",
          "dosing": {
            "doseOptions": [
              {
                "text": "N/A",
                "orderSentence": "Percutaneous radiofrequency thermocoagulation N/A -"
              }
            ],
            "route": "-",
            "instructions": "Thermal lesion of trigeminal ganglion",
            "orderSentence": "Percutaneous radiofrequency thermocoagulation N/A -"
          },
          "contraindications": "Same",
          "monitoring": "Corneal anesthesia risk (V1); recurrence",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "-",
          "ICU": "-"
        },
        {
          "item": "Stereotactic radiosurgery (Gamma Knife)",
          "route": "-",
          "indication": "-",
          "dosing": {
            "doseOptions": [
              {
                "text": "N/A",
                "orderSentence": "Stereotactic radiosurgery (Gamma Knife) N/A -"
              }
            ],
            "route": "-",
            "instructions": "Single high-dose radiation to trigeminal root; effect delayed 1-3 months",
            "orderSentence": "Stereotactic radiosurgery (Gamma Knife) N/A -"
          },
          "contraindications": "None absolute; prior radiation relative",
          "monitoring": "Delayed response; facial numbness (10-30%)",
          "ED": "-",
          "HOSP": "-",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "Microvascular decompression (MVD)",
          "route": "-",
          "indication": "-",
          "dosing": {
            "doseOptions": [
              {
                "text": "N/A",
                "orderSentence": "Microvascular decompression (MVD) N/A -"
              }
            ],
            "route": "-",
            "instructions": "Definitive surgery; move offending vessel; craniotomy",
            "orderSentence": "Microvascular decompression (MVD) N/A -"
          },
          "contraindications": "High surgical risk; no vascular compression",
          "monitoring": "Hearing loss (1-2%), facial numbness (3%), stroke (<1%), recurrence 15-20% at 10 years",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "-",
          "ICU": "-"
        }
      ],
      "Treatment for Specific Subtypes": [
        {
          "item": "Classical TN with clear vascular compression"
        },
        {
          "item": "Classical TN without compression/idiopathic"
        },
        {
          "item": "TN due to MS"
        },
        {
          "item": "TN due to tumor"
        },
        {
          "item": "TN with concomitant continuous pain"
        },
        {
          "item": "V1 distribution"
        }
      ]
    },
    "Other Recommendations": {
      "Referrals & Consults": [
        {
          "item": "Neurology",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-",
          "indication": "Diagnosis confirmation; medication management; atypical cases"
        },
        {
          "item": "Neurosurgery",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-",
          "indication": "Refractory to medical therapy; MVD evaluation"
        },
        {
          "item": "Pain management",
          "ED": "-",
          "HOSP": "-",
          "OPD": "ROUTINE",
          "ICU": "-",
          "indication": "Interventional procedures; multimodal pain"
        },
        {
          "item": "Dentistry/oral surgery",
          "ED": "-",
          "HOSP": "-",
          "OPD": "ROUTINE",
          "ICU": "-",
          "indication": "Exclude dental pathology"
        },
        {
          "item": "Ophthalmology",
          "ED": "-",
          "HOSP": "-",
          "OPD": "ROUTINE",
          "ICU": "-",
          "indication": "V1 involvement; corneal protection if sensory loss"
        },
        {
          "item": "Neuro-oncology",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-",
          "indication": "If tumor-related TN"
        },
        {
          "item": "MS specialist",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-",
          "indication": "If MS-related TN"
        }
      ],
      "Patient/Family Instructions": [
        {
          "item": "TN is a chronic condition; medications can control but rarely cure",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE"
        },
        {
          "item": "Identify and avoid triggers (cold wind, chewing, talking, touching face)",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE"
        },
        {
          "item": "Take medications consistently; do not stop suddenly (taper)",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE"
        },
        {
          "item": "Report rash immediately (especially with carbamazepine, lamotrigine) - may indicate SJS",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE"
        },
        {
          "item": "Report excessive drowsiness, confusion, difficulty walking",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE"
        },
        {
          "item": "Soft diet if chewing triggers attacks",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE"
        },
        {
          "item": "Surgical options exist for medication-refractory cases",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE"
        },
        {
          "item": "Trigeminal Neuralgia Association (tna-support.org) resources",
          "ED": "-",
          "HOSP": "-",
          "OPD": "ROUTINE"
        }
      ],
      "Pre-Procedure Considerations": [
        {
          "item": "Discuss risks/benefits of all surgical options",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE"
        },
        {
          "item": "MVD: Craniotomy risks (hearing loss, stroke, infection, CSF leak, facial numbness)",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE"
        },
        {
          "item": "Percutaneous procedures: Facial numbness expected (30-50%); anesthesia dolorosa rare",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE"
        },
        {
          "item": "Radiosurgery: Delayed onset (weeks-months); facial numbness (10-30%)",
          "ED": "-",
          "HOSP": "-",
          "OPD": "ROUTINE"
        },
        {
          "item": "V1 involvement: Discuss corneal protection if sensory loss anticipated",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE"
        }
      ]
    }
  },
  "differential": [
    {
      "diagnosis": "Dental pain",
      "features": "Related to specific tooth; continuous; percussion tenderness",
      "tests": "Dental exam, X-ray"
    },
    {
      "diagnosis": "TMJ disorder",
      "features": "Jaw pain; clicking; related to chewing; bilateral possible",
      "tests": "Clinical exam; MRI TMJ"
    },
    {
      "diagnosis": "Cluster headache",
      "features": "Periorbital; autonomic features (tearing, rhinorrhea, ptosis); longer attacks",
      "tests": "History; ICHD-3 criteria"
    },
    {
      "diagnosis": "SUNCT/SUNA",
      "features": "Very brief attacks; prominent autonomic features",
      "tests": "History; ICHD-3 criteria"
    },
    {
      "diagnosis": "Post-herpetic neuralgia",
      "features": "History of zoster; dermatomal; continuous",
      "tests": "History; rash history"
    },
    {
      "diagnosis": "Glossopharyngeal neuralgia",
      "features": "Throat/ear pain; triggered by swallowing",
      "tests": "History; carbamazepine response"
    },
    {
      "diagnosis": "Migraine",
      "features": "Longer attacks; photophobia, phonophobia; nausea",
      "tests": "History"
    },
    {
      "diagnosis": "Atypical facial pain",
      "features": "Continuous; crosses trigeminal boundaries; psychiatric comorbidity",
      "tests": "Diagnosis of exclusion"
    },
    {
      "diagnosis": "Giant cell arteritis",
      "features": "Age >50; V1 distribution; jaw claudication; elevated ESR",
      "tests": "ESR, CRP; temporal artery biopsy"
    },
    {
      "diagnosis": "Nasopharyngeal carcinoma",
      "features": "Numbness (painful neuropathy); cranial nerve palsies",
      "tests": "MRI; biopsy"
    },
    {
      "diagnosis": "Acoustic neuroma",
      "features": "V5 distribution numbness; hearing loss",
      "tests": "MRI with IAC protocol"
    }
  ],
  "evidence": [
    {
      "recommendation": "Carbamazepine first-line for TN",
      "evidenceLevel": "Class I, Level A",
      "source": "Multiple RCTs; [AAN/EFNS Guidelines 2008](https://pubmed.ncbi.nlm.nih.gov/18716236/), reaffirmed"
    },
    {
      "recommendation": "Oxcarbazepine as effective alternative",
      "evidenceLevel": "Class I, Level B",
      "source": "Multiple RCTs"
    },
    {
      "recommendation": "MVD most effective long-term for classical TN with compression",
      "evidenceLevel": "Class II, Level B",
      "source": "Multiple case series; long-term outcome data"
    },
    {
      "recommendation": "Percutaneous procedures effective for refractory TN",
      "evidenceLevel": "Class II, Level B",
      "source": "Multiple case series"
    },
    {
      "recommendation": "Stereotactic radiosurgery effective",
      "evidenceLevel": "Class II, Level B",
      "source": "Multiple case series"
    },
    {
      "recommendation": "HLA-B*1502 testing before carbamazepine in Asians",
      "evidenceLevel": "Class I",
      "source": "FDA recommendation"
    },
    {
      "recommendation": "Lamotrigine effective as add-on therapy",
      "evidenceLevel": "Class II, Level B",
      "source": "RCTs"
    },
    {
      "recommendation": "Baclofen effective as add-on",
      "evidenceLevel": "Class III, Level C",
      "source": "Small studies"
    }
  ],
  "monitoring": [
    {
      "item": "Pain frequency/severity (diary)",
      "ED": "-",
      "HOSP": "Daily",
      "OPD": "Every visit",
      "ICU": "-",
      "frequency": "Ongoing",
      "action": "Adjust medications; consider procedures"
    },
    {
      "item": "CBC (carbamazepine)",
      "ED": "-",
      "HOSP": "ROUTINE",
      "OPD": "q2-4 weeks × 3 months, then q3-6 months",
      "ICU": "-",
      "frequency": "Per schedule",
      "action": "Hold CBZ if low"
    },
    {
      "item": "LFTs (carbamazepine)",
      "ED": "-",
      "HOSP": "ROUTINE",
      "OPD": "q2-4 weeks × 3 months, then q3-6 months",
      "ICU": "-",
      "frequency": "Per schedule",
      "action": "Hold if significantly elevated"
    },
    {
      "item": "Sodium (oxcarbazepine)",
      "ED": "-",
      "HOSP": "ROUTINE",
      "OPD": "q2-4 weeks initially, then q3 months",
      "ICU": "-",
      "frequency": "Per schedule",
      "action": "Reduce dose; fluid restrict"
    },
    {
      "item": "Carbamazepine level",
      "ED": "-",
      "HOSP": "-",
      "OPD": "ROUTINE",
      "ICU": "-",
      "frequency": "If breakthrough pain, toxicity, or compliance concern",
      "action": "Adjust dose"
    },
    {
      "item": "Rash surveillance",
      "ED": "STAT",
      "HOSP": "STAT",
      "OPD": "Every visit",
      "ICU": "STAT",
      "frequency": "Ongoing",
      "action": "STOP carbamazepine/lamotrigine immediately; evaluate for SJS"
    },
    {
      "item": "Neurologic exam (post-procedure)",
      "ED": "-",
      "HOSP": "Daily",
      "OPD": "Every visit",
      "ICU": "-",
      "frequency": "Post-procedure",
      "action": "Evaluate for complications"
    }
  ],
  "disposition": [
    {
      "disposition": "Outpatient management",
      "criteria": "Diagnosis confirmed; pain controlled with oral medications"
    },
    {
      "disposition": "Admit to hospital",
      "criteria": "Severe uncontrolled pain requiring IV therapy; severe medication side effects; post-surgical monitoring"
    },
    {
      "disposition": "Neurology follow-up",
      "criteria": "q1-2 weeks during medication titration; q3-6 months when stable"
    },
    {
      "disposition": "Neurosurgery follow-up",
      "criteria": "If refractory to medical therapy; post-procedural"
    },
    {
      "disposition": "Urgent follow-up",
      "criteria": "Status trigeminus (continuous attacks); medication failure; new sensory loss"
    }
  ]
}
